Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study of Irinotecan Liposome Combined with 5-FU/LV for the Patients with Advanced Pancreatic Cancer Who Failed to Receive Irinotecan-containing Regimens

NCT06700603 is registered in ClinicalTrials.gov with Rui-hua Xu, MD, PhD as lead sponsor.

NCT NCT06700603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study of Irinotecan Liposome Combined with 5-FU/LV for the Patients with Advanced Pancreatic Cancer Who Failed to Receive Irinotecan-containing Regimens
Lead sponsor
Rui-hua Xu, MD, PhD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 20, 2024
Completion date
December 31, 2026
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer